University of Minnesota
Minneapolis, Minnesota, United States
Purpose
to determine whether a vaccine that establishes abundant tissue-resident memory T cells could prevent Simian Immunodeficiency Virus (SIV) infection in a primate model of Human Immunodeficiency Virus (HIV)
Division
Global Health
Date
November 2015
Region Served
GLOBAL
Committed amount
$2,734,912
Grant topic
Discovery and Translational Sciences, HIV
Duration (months)
54
Grantee location
Minneapolis, Minnesota, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.